Expression Profile of Salivary Adenoid Cystic Carcinoma Associated with Perineural Invasion. Tohoku J. Exp. Med., 2007, 212 (3), [319][320][321][322][323][324][325][326][327][328][329][330][331][332][333][334] Adenoid cystic carcinoma (ACC) is a common salivary gland malignancy characterized by slow but progressive clinical course, proclivity for hematogenous spread and perineural invasion (PNI) that exhibits inherent resistance to complete surgical resection, systemic chemotherapy and conventional radiotherapy. The molecular alterations that underlie its PNI are poorly characterized. We report the combined use of laser capture microdissection (LCM) and high-throughput cDNA microarray to monitor in vivo gene expression profile of salivary ACC and to correlate the profile with PNI. Consecutive section staining with hematoxylin & eosin was applied to 15 cancerous tissues, among which 6 were judged as PNI. Pure cancer cells adjacent to the nerve tracts from 6 cancerous tissues judged as PNI were laser captured, and pure cancer cells from the same 6 tumors distant from the nerve tracts were also procured. Total RNA was extracted, amplified and subjected to cDNA microarray-based expression analysis. The patterns of gene expression were verified by quantitative real-time PCR and immunohistochemistry. As to the result of 6 arrays, a total of 53 genes were identified as being 2-fold or more differentially expressed in PNI cancer cell group as compared to non-PNI cancer cell control. Out of the 53 genes found consistently differentially expressed, 38 were up-regulated and 15 down-regulated. The combined use of LCM and cDNA microarray analysis provides a powerful new approach to monitor the in vivo molecular events of PNI in salivary ACC. These identified novel genes deserve further investigations to elucidate their clinicopathological significance. carcinoma, adenoid cystic; perineural invasion; microarray; laser capture microdissection; gene expression
tumor stage, histological grade, metastatic progression, early development, apoptosis and cell cycle regulation (Frierson et al. 2002; Huang et al. 2003; Patel et al. 2006 ). However, as prognostic biomarker, gene expression profile of ACC associated with PNI was still scanty. Initiation and progression of PNI in ACC is multi-factorial and multi-step processes accompanied by accumulation of alterations. Delineating these genes involved may lead to important new insights into carcinogenesis of ACC.
The elucidation of the genetic events underlying the initiation and progression of PNI in ACC has been hampered by limitations inherent to both in vitro and in vivo methods of study. The most significant limitation of in vitro-based systems is that genetic information derived from cell lines may not accurately reflect the molecular events taking place in the actual tissue milieu from which they were derived. This obstacle may be overcome using the recently developed techniques of laser capture microdissection (LCM). LCM allows for the rapid, reliable, and accurate procurement of cells from specific microscopic regions of tissue sections under direct visualization (Emmert-Buck et al. 1996) . It affords the opportunity to perform molecular genetic analysis of pure populations of ACC cells in their native tissue environment.
The advent of high-density cDNA microarray technology, with its capacity for simultaneous monitoring of thousands of genes, provides a unique opportunity for high-throughput genetic analysis of cancer (Schena et al. 1995) . For ACC, several investigators have demonstrated the use of DNA microarray is beneficial for elucidation of ACC carcinogenesis (Frierson et al. 2002; Huang et al. 2003; Patel et al. 2006) . However, to our knowledge, combined analyses of LCM and microarray in ACC remain scanty. Here we report the first application of combining LCM and cDNA microarray technologies to analyze gene expression in clinical cancer specimens and to correlate the profile with PNI.
Adenoid cystic carcinoma (ACC) is a common subtype of salivary gland malignancy. It represents approximately 7.5% of all salivary gland epithelial malignancies and 4% of all salivary gland neoplasms (Ellis and Auclair 1996) . The neoplasm has a proclivity for invading nerves, but it infrequently spreads via the lymphatic system. ACC has a protracted clinical course with perineural invasion (PNI), local recurrences, hematogenous metastases, and poor response to classical chemotherapeutic approaches (Fordice et al. 1999) . For early stage disease, surgical resection continues to be the mainstay of therapy (Spiro 1995) . In patients with adverse prognostic features including positive surgical margins and PNI, neutron beam radiation therapy has been advocated for decreasing the risk of local recurrence (Douglas et al. 2000) . However, despite aggressive surgical resection and radiotherapy, the disease-specific survival rates are 70% for 5 years, 40% for 10 years and 15% for 15 years (Spiro and Huvos 1992) . Thus, such failure remains a significant obstacle in the longterm cure of patients with ACC, emphasizing the need for a better understanding of the biological factors associated with this malignancy. PNI is the process by which cancer cells wrap around nerves. It was first described by Ernst (1905) . PNI, a frequent occurrence in ACC, is difficult to be identified clinically and this could prevent complete surgical resection (Van der Wal et al. 1990 ). Vrielinck et al. (1988) reported the relationship between PNI and poor prognosis. It has also been observed frequently in certain types of cancer such as melanoma, prostate, and pancreatic carcinomas as well as head and neck cancers and recognized as one of the most important prognostic factors (Faqan et al. 1998; Pour et al. 2003; Ayala et al. 2004; Rahima et al. 2004; Newlin et al. 2005 ). Because of their predilection for nerves, these cancers are known as "neurotropic cancers".
Many clinical and pathological prognostic factors have been described in ACC (tumor stage, PNI, distant hematogenous metastases, postsurgical margin, and histological grade). More recent gene expression profile of ACC has focused on
MATERIALS AND METHODS

Tissues samples for LCM, judgement of PNI and RNA isolation
This investigation was approved by the Ethics Committee on Human Study at School of Stomatology, the Fourth Military Medical University. A total of 15 cancerous tissues obtained at operation from patients with primary ACC between 2004 and 2006 were collected and immediately frozen in liquid nitrogen after removal of portions needed for pathological diagnosis. The tissues were consecutive sectioned at 8 μ m in a cryostat, mounted on uncoated glass slides, stained with hematoxylin & eosin (H&E), validated by immunostaining for S-100 protein and assessed using a microscope. PNI was assessed as positive when cancer cells were seen in the perineurium or neural fascicles (Duraker et al. 2006) . By this criterion, obvious PNI was found in 6 out of the 15 cancerous tissues ( Fig. 1 ). Slides containing frozen sections were immediately fixed in 70% ethanol for 30 sec, stained with H&E, followed by 5-sec dehydration steps in 70, 95, and 100% and a final 5-min dehydration step in xylene. Once air-dried, the sections were laser microdissected with a PixCell II LCM system from Arcturus Engineering (Mountain View, CA, USA). Following the standard protocol of Emmert-Buck et al. (1996) , pure cancer cells adjacent to the nerve tracts from 6 cancerous tissues judged as PNI were laser captured, and pure cancer cells from the same 6 tumors distant from the nerve tracts were also procured ( Fig. 1 ). Two kinds of cancer cells from target population were captured in a number of about 5,000 cells each. Each population was estimated to be > 98% "homogeneous" as determined by microscopic visualization of the captured cells. Their total RNAs were isolated by using PicoPure RNA extraction kit (Arcturus Bioscience, Mountain View, CA, USA). RNA quality was checked with the Agilent 2100 Bioanalyzer (Agilent Technology, Palo Alto, CA, USA) before further amplification and hybridization.
RNA amplification, probe labeling, and hybridization
A high-yield T7-based linear RNA amplification was performed by using the RiboAmp kit (Arcturus Bioscience, Mountain View, CA, USA). Two rounds of RNA amplification were performed to obtain enough amplified RNA (aRNA) for a microarray experiment. To serve as reference in cDNA microarray comparison, a human reference RNA pooled from 9 cell lines (Stratagene, La Jolla, CA , USA) was amplified identically. cDNA was transcribed from aRNA at a quantity of 1.5 μ g per channel in the presence Cy3-or Cy5-dUTP by using Cyscribe First-Strand cDNA Labelling kit (Amersham Biosciences, Piscataway, NJ, USA). Free conjugated dUTP was removed by Millipore Microcon YM-30 column (Millipore Corporation, Billerica, MA, USA). Cy3-labeled cDNA was pooled with Cy5-labeled reference probe in 30 μ l of hybridization solution and hybridized to an Agilent human 1A cDNA microarray ( A g i l e n t Te c h n o l o g y, P a l o A l t o , C A , U S A ) . Hybridization was carried out at 65°C for 17 hrs in a humidified dark chamber (Genetix Ltd., New Milton, UK). After hybridization, slides were washed at the following condition: 2 × SSC/0.1 g/l SDS at 60°C for 10 min, 2 × SSC at room temperature for 10 min, and 0.2 × SSC at room temperature for 10 min.
Scanning, image analysis, and data processing
Washed microarrays were scanned with the GenePix 4000B microarray scanner (Axon Instruments, Inc., Union City, CA, USA) at 535 nm for Cy3 and 625 nm for Cy5. Scanned images were analyzed by using Array-Pro image acquisition software (Media Cybernetics, Inc., Bethesda, MD, USA), an image analysis algorithm was used to quantify the signal and background intensity for each target element. Data normalization was performed by Iowess method using R package (written by Terry Speeds Microarray Data Analysis Group, University of Berkerley, Berkerley, CA, USA). Measurements from dye-swap replicates were average after normalization. Hierarchical Clustering Explorer 3.0 (HCE 3.0) and Spotfire decisionsite 8.0 software were utilized to analyze the data.
Onto-Express (http://vortex.cs.wayne.edu/Projects. html) was used to cluster genes into functionally relevant categories: biological process; cellular component; and molecular function (Khatri et al. 2002; Draghici et al. 2003) . The numbers of genes corresponding to each gene ontology (GO) category among the 53 differentially expressed genes was tallied and compared with the number of genes expected for each GO category based on their representation on the Agilent human 1A cDNA microarray. Significant differences from the expected were calculated with a two-sided binomial distribution. Because of the large number of statistical tests performed, we estimated the Bayesian posterior true positive, posterior true negative, and posterior false negative rates for each of the genes using the mix-o-matic method of Allison et al. (2002) and to illustrate that more genes were observed to be differentially expressed than expected.
Quantitative real-time PCR (QRT-PCR) analysis
The microarray gene expression data were verified by QRT-PCR for a group of selected genes (Table 1) . One-third of the same total RNA pool used for the hybridizations was reverse-transcribed by using Sensiscript Reverse Transciptase for first-strand cDNA synthesis kit (QIAGEN, Valencia, CA, USA), and the resulting first-strand cDNA was diluted and used as tem- The H&E-stained frozen sections of ACC associated with PNI were subjected to LCM as described under Materials and Methods. PNI was assessed as positive by H&E staining (A) and validated by immunostaining for S-100 protein (B). Pure cancer cells adjacent to the nerve tracts were selectively procured and transferred to the cap film (C, D, E). Target cells before laser capture (C); same section after laser capture (D); captured cells on the cap film (E). A, B, C, E, arrow, target cancer cells adjacent to the nerve tracts; D, arrow, residual nerve tracts. N equals to nerve tracts. Original magnification × 100.
plate for the following QRT-PCR analysis. QRT-PCR was performed with QuantiTect SYBR Green PCR master mix (QIAGEN, Valencia, CA, USA) using the Rotor-Gene RG-3000 Real-Time Thermal Cycler (Corbett Reseach, Sydney, Australia) and Rotor-Gene software version 6.0. Each reaction contained 15 μ l SYBR Green master mix, 1 μ l each sense and antisense primer (50 pmol/μ l), 5 μ l cDNA template supplemented with water to a final volume of 25 μ l. A housekeeping gene Human 18S was used as an endogenous control. Primer sequences of human 18S are as follows: forward, 5′-CGGCTACCACA TCCAAGGAA-3′ and reverse, 5′-GCTGGAATTACCG CGGCT-3′. The calibration standard curve was set up by serial dilutions (1-0.0001) of known quantities of mRNA of control sample. The sequences of PCR primer pairs of target genes were as follows ( Table 1) . The primers were positioned to span exon-intron boundaries, reducing the risk of detecting genomic DNA. A negative control (without template cDNA) was included to ensure no crossover DNA contamination. To verify the specificity of the amplification reaction, melting curve analysis was performed.
Each sample was run as a triplicate (n = 3, the dissections and QRT-PCR reactions were all repeated three times per each target area). The average value of triplicates was used as quantitative value of each of growth patterns.
Immunohistochemistry (IHC)
Immunohistochemical staining for melanoma cell adhesion molecule (MCAM, CD146) protein was performed by using a standard peroxidase-conjugated avidinbiotin method as described previously (Sqroi et al. 1999; Wang et al. 2000) . Immunostaining of frozen tissue sections (8 μ m) adjacent to those slides used for LCM were mounted on slides and fixed in 10% neutral buffered formalin for 8 min. The slides were preincubated with mouse serum (1 : 50 dilution) for 20 min at room temperature to block nonspecific binding and incubated with the anti-MCAM (ZhongShan Golden Bridge Biotechology, Beijing, P.R. China) at a 1: 40 dilution for 20 min at room temperature. The slides were washed three times in PBS, incubated with PBS/0.3% H 2 O 2 for 30 min, and washed three times in PBS. Sections were incubated with biotinylated anti-mouse antibody (ZhongShan Golden Bridge Biotechology), washed in PBS, incubated with the ABC reagent (ZhongShan Golden Bridge Biotechology) for 1h, washed, and developed according to the manufacturer's recommendations. The tissue was postfixed in 4% formalin and counterstained with hematoxylin.
RESULTS
Although the combined use of LCM and cDNA arrays provides a unique opportunity to study gene expression of subpopulations of cells in their native (in vivo) tissue environment, such 
Histopathological examination of PNI and microdissection
Primary tumor samples from fifteen patients (nine females, six males) were available for this study. Serial cryosections stained with H&E, validated by immunostaining for S-100 protein, were examined microscopically to confirm the PNI. Obvious PNI was found in 6 out of the 15 cancerous tissues (Fig. 1) . LCM was used to procure pure cell populations. Pure cancer cells adjacent to the nerve tracts from 6 cancerous tissues judged as PNI were laser captured, and pure cancer cells from the same 6 tumors distant from the nerve tracts were also procured. Fig. 1 shows a representative example of LCM.
LCM-based gene expression profiling associated with PNI
We next carried out a genome-wide, arraybased gene expression analysis to identify unique and discriminatory molecular profile associated with PNI. Total RNA of captured cells was isolated. One-third of the isolated RNA was set aside for QRT-PCR validation studies (see below), and the remaining two-thirds were used for the generation of aRNA. Because the captured cells are comprised of only limited numbers of cells ( 5 × 10 3 cells from each target population), the RNA yield is minimal (≈ 50 to 500 fg/cell). Therefore, we combined the use of LCM with linear amplification (LCM-LA), using T7-based linear RNA amplification (Van Gelder et al. 1990; Ivanov et al. 2005) . Despite concerns raised about possible alteration in the original transcript abundance during the amplification steps, recent studies showed that the ratios of gene expression levels in similarly amplified samples remained intact (Poirier et al. 1998; Baugh et al. 2001; Pabon et al. 2001 ). This method routinely gener-ated 70 to 160 μ g of aRNA from laser-captured colonocytes (5,000 to 10,000 cells).
The expression levels of genes in ACC tissue samples with and without PNI were determined by hybridization of RNA to oligonucleotide microarray comprising 20,173 probe sets representing 18,716 unique human genes (listed by RefSeq numbers and genebank ID) and 1,457 expressed sequence tags (ESTs). Of 18,716 interrogated genes and 1,457 ESTs, analyzed data showed 53 genes were differentially expressed (fold difference 2.0 or 1/2) among all 6 arrays that could distinguish PNI and non-PNI cancer cell groups. Of the 53 genes found differentially expressed, 38 were up-regulated and 15 down-regulated. Genes that are significantly and differentially regulated (up or down) at least 2-fold between PNI and non-PNI groups among all 6 arrays are represented in Table 2 and 3.
To visualize the gene expression data, gene ontology classification and hierarchical clustering was performed using the 53 genes with the differential variances that satisfied stringent filtering criteria ( p < 0.001, Δ > 100, fold difference 2.0 or 1/2). This unsupervised analysis resulted in a clustering of the samples that corresponded well to the PNI (Fig. 2 and Table 4 ). The 53 genes could be divided into five clusters discriminating the PNI (Fig. 2) . Clusters 1 (n = 12) and 2 (n = 12) consisted of genes that were mainly highly and moderately up-regulated in PNI groups compared with non-PNI cancer cells groups. Among these were genes for transmembrane protein (NETO1), metabolic processes (APOC1), metalloprotease (ADAM30), oncogene (MCAM), extracellular matrix (COL4A3, COL4A6), apoptosis related (CARD12) and regulation of cell cycle (CCNB1, CCNB3). Clusters 3 (n = 9) and 4 (n = 5) consisted of genes that were mainly members of SOX (SRY-related HMG-box), Notch and WNT families. Among these were genes for sequencespecific DNA binding (SOX2, SOX5 and SOX11) and signal transduction (WNT2B, NOTCH4). The group 5 cluster of genes (n = 15) all down-regulated in PNI cancer cells is significantly represented by genes involved in oncogene (MAGEA2, MAGEA3, MAGEA4, MAGEA6 and MAGEA9), 
Validation of array data by QRT-PCR and IHC
To confirm the findings of the microarray analysis we performed QRT-PCR analysis using primers specific for MCAM (CD146), MGEA6, CARD12, PMP22, TRAG-3, MAGEA2 and MAGEA6 and compared the fold differences in expression predicted by microarray to that obtained by QRT-PCR. These genes were selected for confirmation because of their prominent folder changes or important functions in neurogenesis, tumor invasion and metastasis. To obtain truly comparable results, the third fraction of the original total RNA (from the same batch that was used for the array hybridizations) was used as a template in the QRT-PCR reactions. Table 1 and Fig. 3 demonstrate that the differential expression pattern and the quantitative expression level of each of the seven genes as determined by QRT-PCR were similar to those observed with cDNA arrays, confirming the reliability of our array expression profile data.
As an additional means to confirm our data at the protein level, we performed IHC analysis of MCAM (CD146) using tissue sections that were adjacent to those used for laser microdissection. Paralleling the differential expression pattern observed with the cDNA microarray and QRT-PCR analysis, the sections of cancerous tissues with PNI demonstrated abundant and strong immunoreactivity for MCAM (CD146), whereas the sections tissues of the same tumor without PNI demonstrated weaker immunoreactivity (Fig.  4) . This result further supports the reliability of our expression data and demonstrates the cellular specificity of the MCAM (CD146) gene expression. Overall, the QRT-PCR and IHC results support the feasibility of our microarray experimental protocol as a means to assess in vivo transcript expression profiles.
DISCUSSION
The objectives of this study were to investigate the range of gene expression differences between PNI and non-PNI ACC cell groups and to correlate gene expression signatures with PNI Our results concur with a recently published gene expression profiling study by Frierson et al. (2002) , evaluating 15 ACC tumors, the ACC3 cell line and 5 normal major salivary gland tissues. Compared with the list of 30 genes identified as most overexpressed in ACC in the Frierson study, 14 genes or their gene family members were also identified as overexpressed in our dataset (NMA, FLJ13612, SOX2, SOX5, SOX11, SOX15, SOX17, NOTCH4, CCNB1, CCNB3, RNPC2, COL4A3, COL4A6, DNMT3B) . Our results also consist with another recently published gene expression profiling study by Patel et al. (2006) , evaluating 8 ACC tumors, the ACC3 cell line and 4 normal major salivary gland tissues. Compared with the list of 45 genes identified as most up-regulated in ACC in the Patel study, 19 genes or their gene family members were also identified as upregulated in our dataset (FANCA, SERPINF1, FLJ13612, SOX2, SOX5, SOX11, SOX15, SOX17, Fig. 2 
. Hierachical clustering of gene expression
profiles from PNI ACC cell group relative to non-PNI ACC cell group. Filtered 53 genes with the differential variances were clustered by the pattern of up-regulation (red) and down-regulation (green). These genes could be divided into five clusters discriminating PNI in the dendrogram. Red, increased gene expression; green, decreased gene expression; black, median level of gene expression. Hump diagram indicates distribution of all data. The numerical value on Y axle indicates the characteristic value of data distribution, and the numerical value on X axle indicates the characteristic value of data cluster analysis. NETO1, CCNB1, CCNB3, WNT2B, WNT3, WNT11, NOTCH4, RNPC2, COL4A3, COL4A6, DNMT3B). Clearly these genes represent attractive candidates for further study of ACC pathobiology. In addition, our data implicate a role for several novel genes in initiation and progression of PNI in ACC including MCAM (CD146), AREG, MGEA6, CARD12, PMP22, MMP7, APOC1, MAGEA2, MAGEA3, MAGEA4, MAGEA6 and MAGEA9. SOX2, SOX5, SOX11, SOX15 and SOX17 are members of the SOX family of transcription factors. The SOX gene family members have a highly conserved HMG-domain responsible for sequence-specific DNA binding (Laudet et al. 1993) . Although they share similar DNA-binding properties, the individual SOX proteins use specific partners to regulate different sets of target genes (Kamachi et al. 2000; Tanaka et al. 2004 ). There is accumulating evidence that SOX2 con- trols the expression of several developmentally important genes (SOX2, Oct4, Nanog, nestin, δ -crystalline, fibroblast growth factor 4, undifferentiated embryonic cell transcription factor 1 and F-box-containing protein 15); hence, it plays a crucial role in embryonic development (Pevny et al. 1997; Wegner et al. 1999; Kamachi et al. 2000; Avilion et al. 2003; Uchikawa et al. 2003; Catena et al. 2004; Miyagi et al. 2004 ). SOX2 appears to act upstream of the Notch signaling pathway to maintain the cell proliferative potential in the developing neocortex (Bani-Yaghoub et al. 2006) . SOX2 interacts directly with a NOTCH1 enhancer, and that, in turn, the levels of SOX2 directly correlate with the levels of NOTCH1 (Taranova et al. 2006) . By down-regulating Ihh signaling, Fgfr3, and Runx2 and by up-regulating BMP6, SOX5, SOX6, and SOX9 combination (the SOX trio) are needed for the establishment of multilayered growth plates, and for proper and timely development of permanent cartilage and endochondral bones (Ikeda et al. 2004; Smits et al. 2004) . SOX11 is prominently expressed in the developing nervous system in both glial and neuronal lineages and at many sites throughout the embryo where epithelial-mesenchymal interactions occur (Uwanogho et al. 1995; Hargrave et al. 1997; Kuhlbrodt et al. 1998) . Studies suggest that the expression of SOX15 is restricted to the fetal testis, and is found to be strongly upregulated in the adult mouse testis, indicating a possible role in testis development (Hiraoka et al. 1998; Sarraj et al. 2003) . Studies show that β -catenin, a component of Wnt signaling pathway, physically interacts with SOX17 and potentiates its transcriptional activation of endodermal target genes (Sinner et al. 2004; Park et al. 2006) . Our data and other independent works have shown the remarkable overexpression of the SOX, Notch, and WNT gene family members in ACC (Frierson et al. 2002; Patel et al. 2006) . It is interesting to speculate from these data that the SOX genes may play an important role in initiation and progression of PNI in ACC through Notch and Wnt/β -catenin signaling pathways. Another interesting gene identified in the PNI signature is Taxol resistance-associated gene 3 (TRAG-3). TRAG-3, originally identified as a taxol resistance-associated gene from an ovarian carcinoma cell line, has been reported to be a tumor/testis antigen later (Duan et al. 1999; Feller et al. 2000) . TRAG-3 is located on chromosome Xq28 and flanked by the MAGE (melanoma-antigen gene) gene cluster (which includes MAGEA2, A3, A4, A5, A10, and A12) and the CENT2 gene (Errabolu et al. 1994; Rogner et al. 1995) . Like the MAGE family antigens, TRAG-3 is usually absent or transcribed at trace levels in the majority of normal tissues, including kidney, liver, lung, pancreas, muscle, brain, and heart (Duan et al. 1999; Feller et al. 2000) . However, it is usually abundantly expressed in testis. TRAG-3 is frequently overexpressed in many tumor cell lines, especially in melanoma (Duan et al. 1999; Feller et al. 2000) and colorectal tumors (Nimmrich et al. 2000) . Recent evidence indicate that DNA demethylation is an important epigenetic mechanism that regulates several tumor/testis antigens such as MAGE family proteins, and the TRAG-3 tumor antigen in human tumors (Serrano et al. 1996; Jang et al. 2001; Yao et al. 2004) . A recent study shows that TRAG-3 overexpression is associated with overexpression of neighboring genes (MAGE cluster genes and CENT2) (Duan et al. 2003) . MAGEA2 and MAGEA6 could induce paclitaxel and doxorubicin resistance (Duan et al. 2003) . In our data, MAGEA2, A3, A4, A6, A9 and TRAG-3 are all down regulated in PNI group, which concurs with the upper study. Though the lower expression level of TRAG-3 and MAGE genes in PNI group suggests that ACC with PNI may be more sensitive to paclitaxel therapy, this hypothesis requires additional validation.
Other classifier genes in PNI cell groups include MCAM and AREG. MCAM, also named CD146, MUC18, A32 antigen and S-Endo-1 (Lehmann et al. 1989; Shih et al. 1994; Bardin et al. 1996) . MCAM is a novel member of the immunoglobulin gene superfamily and contains five extracellular Ig-like domains (V-V-C2-C2-C2), one transmembrane region and a short cytoplasmic tail (Lehmann et al. 1989) . MCAM is expressed in more than 90% of cutaneous melanomas and its expression level is associated with the invasive and metastatic potential of melanoma cells (Luca et al. 1993; Shih et al. 1994) . Increased MCAM expression in melanoma cells promotes tumor growth and metastasis and decreased MCAM expression reduces tumorigenicity (Xie et al. 1997; Satyamoorthy et al. 2001) . Recent study demonstrates that MCAM, as an active endothelial marker, is involved in angiogenesis, which plays an important role in tumor growth and metastasis (Yan et al. 2003) . AREG is a heparin-binding, heparin-inhibited member of the epidermal growth factor family and an autocrine growth factor for human keratinocytes (Pathak et al. 1995) . AREG mRNA was expressed in a variety of human tumors, such as colorectal cancer, liver cancer, gastric cancer, breast cancer, prostate cancer, esophageal cancer and myeloma (Katoh and Katoh 2006) . Because human AREG was characterized as potent target gene of Wnt/ β -catenin signaling pathway, WNT signaling activation could lead to anti-cancer drug Gefitinib (Iressa) resistance through AREG upregulation. AREG is a target of systems medicine in the field of oncology (Katoh and Katoh 2006) . A gene expression profile of mouse hepatocarcinoma cell lines associated with lymphatic metastasis shows that MCAM and AREG participate in lymphatic metastasis (Song et al. 2005) . From these data all of above, we may speculate that MCAM and AREG play an important role in invasive and metastatic potential of ACC cells.
In these above-mentioned genes, some are related significantly to poor prognosis, including up-regulated and down-regulated genes. Increased MCAM expression is predicted as a marker of early relapse and shortened patient survival in melanoma, epithelial ovarian cancer, and adenocarcinoma of the lung (Johnson 1999; Kristiansen et al. 2003; Aldovini et al. 2006) . Genes participating in Wnt/β -catenin signaling pathway are also judged as potential markers of prognosis and targets for therapeutic intervention. A recent study shows that WNT5A is not only a prognostic factor but also a good therapeutic target for gastric cancer (Kurayoshi et al. 2006) . Another evidence indicates that high levels of WNT1 and β -catenin expression are associated with advanced, metastatic, hormone-refractory prostate carcinoma, in which they can serve as markers of disease progression (Chen et al. 2004 ). Overexpression of β -catenin appears to have pathologic and prognostic significance in colorectal cancer and hepatocellular carcinoma (Wong et al. 2001; Martensson et al. 2007 ). An interesting study shows that BAGE or GAGE expression is related significantly to poor prognosis in esophageal carcinoma, whereas the expression of MAGE genes (in the absence of BAGE and GAGE expression) is related significantly to good prognosis (Zambon et al. 2001) . Thus, decreased expression of MAGE genes may lead to poor prognosis in esophageal carcinoma. Based on these data mentioned above, we speculate that increased expression of MCAM and genes participating in Wnt/β -catenin signaling pathway may lead to poor prognosis in ACC, and decreased expression of MAGE genes as well.
Using carefully controlled conditions, we demonstrated that in vivo subpopulations of malignant cells from ACC with PNI can be screened for tens of genes. We now report the feasibility of combining LCM and high-throughput cDNA microarray analysis to study in vivo gene expression profile and we illustrate through the use of duplicate hybridizations, QRT-PCR analysis, and IHC that this approach produces reproducible and valid data. Several genes previously identified as overexpressed in ACC were confirmed by our study in addition to identifying several novel genes with potential roles in the pathobiology of ACC associated with PNI. Future work focusing on the function of these genes in normal and malignant salivary gland tissues and the exploration redifferentiation, or other therapies based on functional gene ontology relationships, will hopefully lead to improved outcomes for patients with ACC.
